Relmada Therapeutics (RLMD) Tops Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel rattle AI trade
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| (NASDAQ: RLMD) | Delayed: 3.61 +0.17 (4.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.44 | 52 Week High | $4.10 | |||
| Open | $3.42 | 52 Week Low | $0.87 | |||
| Day High | $3.61 | P/E | N/A | |||
| Day Low | $3.30 | EPS | $0.00 | |||
| Volume | 484,830 | |||||
